Get some sleep, set the alarm and put on the coffee, it's time for the British Open ... and that means it's time for another golf roundtable, featuring Yahoo Sports senior writer Jay Busbee and Yahoo Sports fantasy impresario Scott Pianowski. Topics today: Which players to chase and which to fade, the impact of weather on the tournament, and whether the British Open is the best major of them all. Let's begin!
, another glorious swinger with a light collection of trophies . Spoiler, I probably swing more like Mick Fleetwood than Tommy Fleetwood. Maybe something happens to Tommy on Sundays? He's just 80th in final-round scoring. It's asking too much for him to break through at a major.We've got to talk about the big dogs, including You-Know-Who.
If you have to bet on a favorite, Scottie Scheffler makes a lot of sense. His 2023 results read like a misprint. Seven straight Top 5s, 18 straight Top 12s, the win at Phoenix, the win at The Players. He’s been striking the ball much better than anyone, and giving back much of that through a baffling putting slump. Well, good news, Texan, this is a lush and likely soft course that doesn’t have complicated greens. You can beat everyone tee to green and make it hold up.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
British Open Odds, Field 2023 — The Open Championship OddsRory's run at the 150th British Open last year certainly didn't end how he wanted, but he enters this year's edition in even stronger form and gets to return to the venue of his 2014 win.
Read more »
How One of the Ocean’s Largest, Most Elusive, and Expensive Shellfish Is FarmedHow one of the ocean’s largest, most elusive, and expensive shellfish is farmed
Read more »
How One of the Ocean’s Largest — and Most Expensive — Shellfish Is FarmedThe giant clams known as geoducks can go for as much as $100 a plate.
Read more »
Pfizer, Flagship Pioneering to invest $100 mln for drug discoveryU.S. drugmaker Pfizer and venture capital firm Flagship Pioneering on Tuesday agreed to invest $100 million to discover and develop 10 new potential drugs targeting diseases with few or no treatment options.
Read more »